Journal of Applied Physiology, Vol 72, Issue 1 1-7, Copyright © 1992 by American Physiological Society

ARTICLES

Tissue-specific regulation of inflammation

H. R. Colten
Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110.

Proteins of the complement system are important effectors and modulators of inflammation. The complement cascade is triggered by microbes, tissue debris, and specific antibodies. Serum complement proteins are derived primarily from liver, but extrahepatic complement synthesis is important in homeostasis and in local host defenses. Tissue-specific regulation of expression of complement genes is governed by mechanisms similar to those that regulate other "acute phase reactants." That is, tissue injury or infection elicit changes in expression of these acute phase proteins, which, although variable in kinetics, magnitude, and direction, are a consequence of an elaborate system of cell-to-cell communication. This communication is mediated via a complex network of cytokines, including the interferons, interleukins, several growth factors, and sex hormones. The cell biological and molecular biological details of these mechanisms are now under active investigation. An understanding in molecular terms of the balance between proinflammatory and counterregulatory forces on complement gene expression should provide new insight into the functions of complement and the design of novel therapies for disorders of inflammation.

This article has been cited by other articles:

				C. A. Farrar, W. Zhou, T. Lin, and S. H. Sacks Local extravascular pool of C3 is a determinant of postischemic acute renal failure FASEB J, February 1, 2006; 20(2): 217 - 226. [Abstract] [Full Text] [PDF]

				A. W. Deckel, D. Cohen, and R. Duckrow Cerebral blood flow velocity decreases during cognitive stimulation in Huntington's disease Neurology, December 1, 1998; 51(6): 1576 - 1583. [Abstract] [Full Text] [PDF]

				D. MacLean, J. Vissing, S. F. Vissing, and R. G. Haller Oral branched-chain amino acids do not improve exercise capacity in McArdle disease Neurology, November 1, 1998; 51(5): 1456 - 1459. [Abstract] [Full Text] [PDF]

				R. J. Quigg, C. He, A. Lim, D. Berthiaume, J. J. Alexander, D. Kraus, and V. Michael Holers Transgenic Mice Overexpressing the Complement Inhibitor Crry as a Soluble Protein Are Protected from Antibody-induced Glomerular Injury J. Exp. Med., October 5, 1998; 188(7): 1321 - 1331. [Abstract] [Full Text] [PDF]

				R. G. Haller, T. Clausen, and J. Vissing Reduced levels of skeletal muscle Na+K+-ATPase in McArdle disease Neurology, January 1, 1998; 50(1): 37 - 40. [Abstract] [Full Text] [PDF]

				J. Vissing, H. Galbo, and R. G. Haller Paradoxically enhanced glucose production during exercise in humans with blocked glycolysis caused by muscle phosphofructokinase deficiency Neurology, September 1, 1996; 47(3): 766 - 771. [Abstract] [Full Text] [PDF]